Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Fragment Screening
100%
Hereditary Angioedema
66%
Fragment-based Drug Discovery
66%
High Concentration
66%
Microfluidic Experiments
66%
Coagulation Factors
66%
In Vivo Function
33%
Emerging Research Topics
33%
Phage Display Library
33%
Kallikrein-kinin System
33%
Hematophagous Arthropods
33%
Library Technology
33%
Hit-to-lead
33%
Neuroinflammatory Disorders
33%
Thrombosis Model
33%
Generation Time
33%
Anticoagulant Property
33%
Evolution Process
33%
FXIIa
33%
Pharmacophore Model
33%
Contact Phase
33%
Affinity Capillary Electrophoresis
33%
Blood Coagulation
33%
Thrombin Generation
33%
Antithrombotic Drugs
33%
Arterial Thrombosis
33%
Low Dose Rate
33%
Discovery Approach
33%
Coagulation Assays
33%
Drug Structure
33%
Therapy-related
33%
Selective Inhibitor
33%
Structure-activity Relationship
33%
Computer-aided Drug Design
33%
Hemorrhage
33%
Venous Thrombosis
33%
Capillary Electrophoresis Methods
33%
Design Activity
33%
Structure-selectivity Relationship
33%
Clotting Time Assays
33%
Preclinical Evaluation
33%
Serine Protease
33%
Whole Blood
33%
In Vitro Enzymatic Assay
33%
Microfluidic Model
33%
Protein Plug
22%
Screening Technology
22%
Coated Capillary
22%
Sample Purity
22%
Zinc Contamination
22%
Plug Length
22%
INIS
affinity
86%
screening
83%
capillaries
83%
electrophoresis
83%
tools
66%
drugs
66%
applications
66%
evaluation
43%
bioassay
33%
concentration
33%
kinins
33%
lead compounds
33%
length
26%
voltage
26%
therapy
16%
design
16%
optimization
16%
anticoagulants
16%
research programs
16%
thrombin
16%
thrombosis
16%
blood coagulation
16%
hemorrhage
16%
solubility
16%
blood
16%
serine
16%
in vitro
16%
in vivo
16%
computers
16%
comparative evaluations
16%
plasma
16%
spectrophotometry
13%
dissociation
13%
contamination
13%
purity
13%
detection limits
13%
plugs
13%
buffers
13%
zinc
13%
interference
13%
proteins
13%
validation
13%
ph value
13%
ethylene
13%
oxides
13%
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
66%
Anticoagulant Agent
66%
Blood Clotting Factor
66%
Blood Clotting Factor 12
66%
Lead Compound
66%
Bioassay
66%
Thrombin
33%
Computer-Aided Drug Design
33%
Vein Thrombosis
33%
Clotting Time
33%
Capillary Electrophoresis
33%
Serine Proteinase
33%
Artery Thrombosis
33%
Ionic Strength
16%
Angioneurotic Edema
16%
Bacteriophage
8%
Protein Antibody
8%